Kroin David's Form 4 filing
Nektar Therapeutics (NKTR) · filed May 13, 2024
- Accession no.
- 0000950170-24-058720
- Filed
- May 13, 2024, 4:36 PM ET
- Trade date
- May 10, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $99.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kroin DavidCIK 0001397513 | 10% Owner |
| Deep Track Capital, LPCIK 0001856083 | 10% Owner |
| Deep Track Biotechnology Master Fund, Ltd.CIK 0002015536 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | Common Stock | SSaleDisposed | −56,000 | $1.78 | −$99,629.6 | 18,344,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.